Your email has been successfully added to our mailing list.

×
0 0 0.00016548072149603 0.00016548072149603 0.00421975839814666 -0.0101770643720006 -0.0105907661757404 -0.00612278669534995
Stock impact report

GSK's NDA for UTI Drug Gepotidacin Gets FDA's Priority Review [Yahoo! Finance]

ANI Pharmaceuticals, Inc. (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
Company Research Source: Yahoo! Finance
for its investigational, first-in-class oral antibiotic, gepotidacin for treating uncomplicated urinary tract infections (uUTIs) in female adults and adolescents. With the FDA granting a priority review to the NDA, a decision from the regulatory body is expected on March 26, 2025. If approved, gepotidacin could become the first in a new class of oral antibiotic medicines to be approved for treating uUTIs in more than 20 years. Year to date, shares of GSK have increased 5.8% against the industry's decline of 1.8%. Image Source: Zacks Investment Research GSK's NDA Based on Data from Two Phase III Studies The NDA for gepotidacin was based on data from two pivotal phase III studies — EAGLE-2 and EAGLE-3 — which evaluated the safety and efficacy of gepotidacin versus nitrofurantoin, the current standard of care for uUTI. Within the studies, treatment with gepotidacin demonstrated non-inferiority to nitrofurantoin in female adults with confirmed uUTI and a uropathogen suscepti Show less Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ANIP alerts

from News Quantified
Opt-in for
ANIP alerts

from News Quantified